Does ELIGLUSTAT Cause Product dose omission issue? 77 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 77 reports of Product dose omission issue have been filed in association with ELIGLUSTAT (Cerdelga). This represents 5.6% of all adverse event reports for ELIGLUSTAT.
77
Reports of Product dose omission issue with ELIGLUSTAT
5.6%
of all ELIGLUSTAT reports
0
Deaths
4
Hospitalizations
How Dangerous Is Product dose omission issue From ELIGLUSTAT?
Of the 77 reports, 4 (5.2%) required hospitalization.
Is Product dose omission issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ELIGLUSTAT. However, 77 reports have been filed with the FAERS database.
What Other Side Effects Does ELIGLUSTAT Cause?
Weight increased (132)
Weight decreased (111)
Product dose omission in error (110)
Fatigue (69)
Arthralgia (46)
Dyspepsia (46)
Nausea (46)
Covid-19 (41)
Fall (41)
Dizziness (39)
What Other Drugs Cause Product dose omission issue?
DUPILUMAB (18,189)
USTEKINUMAB (9,405)
GUSELKUMAB (9,267)
LENALIDOMIDE (8,145)
MEPOLIZUMAB (5,873)
TOFACITINIB (5,646)
VOXELOTOR (5,122)
BELIMUMAB (4,671)
SECUKINUMAB (4,572)
APREMILAST (4,460)
Which ELIGLUSTAT Alternatives Have Lower Product dose omission issue Risk?
ELIGLUSTAT vs ELIQUIS
ELIGLUSTAT vs ELOSULFASE ALFA
ELIGLUSTAT vs ELOTUZUMAB
ELIGLUSTAT vs ELOXATIN
ELIGLUSTAT vs ELRANATAMAB